Indivior added to S&P SmallCap 600 index, boosting U.S. business profile
Share
Indivior (NASDAQ:INDV) has announced its inclusion in the S&P SmallCap 600 index, effective December 22, 2025.
The company stated that this milestone aligns its capital markets presence with a sharpened U.S. business profile and supports the growth of SUBLOCADE, its first-in-class long-acting injectable for moderate to severe opioid use disorder.
The S&P SmallCap 600 tracks 600 U.S. small-cap companies with market capitalizations typically ranging between $1.2 billion and $8 billion, with additional liquidity and viability criteria for inclusion.
Indivior's addition to the index reflects its growing influence and potential in the healthcare sector, underscoring its commitment to expanding its U.S. footprint.